|
Volume
25 Number 4
28 February 2023
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
25, Year 2023 >
Number 4, 28 February
|
|
|
|
|
|
Pant A, Lim
M.
CAR-T
Therapy in GBM: Current Challenges and Avenues for
Improvement.
Cancers
(Basel). 2023 Feb 16;15(4):1249→.
doi: 10.3390/cancers15041249→.
PMID: 36831591→.
Review. ˍ
|
|
|
|
Stella M,
Baiardi G, Pasquariello S, Sacco F, Dellacasagrande I, Corsaro A,
Mattioli F, Barbieri F.
Antitumor
Potential of Antiepileptic Drugs in Human Glioblastoma:
Pharmacological Targets and Clinical Benefits.
Biomedicines.
2023 Feb 16;11(2):582→.
doi: 10.3390/biomedicines11020582→.
PMID: 36831117→.
Review. ˍ
|
|
|
|
Chalif EJ,
Foster C, Sack K, Patrick H, Mozaffari K, Rosner M.
Impact
of Extent of Resection and Adjuvant Therapy in Diffuse Gliomas of
the Spine.
Spine
J. 2023 Feb 17:S1529-9430(23)00074-8→.
doi: 10.1016/j.spinee.2023.02.010→.
PMID: 36804437→.
Observational
study, Review˰ ˍ
|
|
|
|
Ibne Mokbul
M, Siddik AB.
Relationship
between glioblastoma multiforme (GBM) and Alzheimer's disease
(AD): is there any reporting bias?
Med
Oncol. 2023 Feb 21;40(3):101→.
doi: 10.1007/s12032-023-01951-9→.
PMID: 36809382→.
Editorial˰ ˍ
|
|
|
|
Tamai S,
Ichinose T, Nakada M.
Liquid
biomarkers in glioma.
Brain
Tumor Pathol. 2023 Feb 17→.
doi: 10.1007/s10014-023-00452-x→.
PMID: 36800124→.
Review˰ ˍ
|
|
|
|
Angolkar M,
Paramshetti S, Halagali P, Jain V, Patil AB, Somanna
P.
Nanotechnological
advancements in the brain tumor therapy: a novel approach.
Ther
Deliv. 2023 Feb 21→.
doi: 10.4155/tde-2022-0035→.
PMID: 36802944→.
Review˰ ˍ
|
|
|
|
De Roeck L,
Gillebert RC, van Aert RCM, Vanmeenen A, Klein M, Taphoorn MJB,
Gehring K, Lambrecht M, Sleurs C.
Cognitive
outcomes after multimodal treatment in adult glioma patients: A
meta-analysis.
Neuro
Oncol. 2023 Feb 21:noad045→.
doi: 10.1093/neuonc/noad045→.
PMID: 36809489→.
Meta-analysis. ˍ
|
|
|
|
Fudaba H,
Wakimoto H.
Oncolytic
virus therapy for malignant gliomas: entering the new era.
Expert
Opin Biol Ther. 2023 Feb 21→.
doi: 10.1080/14712598.2023.2184256→.
PMID: 36809883→.
Review˰ ˍ
|
|
|
|
Schaff LR,
Mellinghoff IK.
Glioblastoma
and Other Primary Brain Malignancies in Adults: A Review.
JAMA.
2023 Feb 21;329(7):574-587→.
doi: 10.1001/jama.2023.0023→.
PMID: 36809318→.
Review˰ ˍ
|
|
|
|
Guzman G,
Pellot K, Reed MR, Rodriguez A.
CAR
T-cells to treat brain tumors.
Brain
Res Bull. 2023 Feb 23:S0361-9230(23)00048-5→.
doi: 10.1016/j.brainresbull.2023.02.014→.
PMID: 36841424→.
Review. ˍ
|
|
|
|
Barden MM,
Omuro AM.
Top
advances of the year: Neuro-oncology.
Cancer.
2023 Feb 24→.
doi: 10.1002/cncr.34711→.
PMID: 36825454→.
Review˰ ˍ
|
|
|
|
Baqai MWS,
Tariq R, Shah Z, Bajwa MH, Shamim MS.
Quality
of life in survivors of pediatric medulloblastoma: a systematic
review and meta-analysis.
Childs
Nerv Syst. 2023 Feb 24→.
doi: 10.1007/s00381-023-05886-4→.
PMID: 36826523→.
Review, Meta-analysis˰ ˍ
|
|
|
|
Schupper AJ,
Hadjipanayis CG.
Novel
approaches to targeting gliomas at the leading/cutting edge.
J
Neurosurg. 2023 Feb 24:1-9→.
doi: 10.3171/2023.1.JNS221798(?). PMID: 36840741→.
Review˰ ˍ
|
|
|
|
Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF,
Goldbrunner R, Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane
M, Razis E, Roth P, Rudà R, Tabatabai G, Wen PY, Short SC,
Preusser M.
Diagnosis and management of
complications from the treatment of primary central nervous system
tumors in adults.
Neuro Oncol. 2023 Feb 27:noad038→.
doi: 10.1093/neuonc/noad038→.
PMID: 36843451→.
Review.
ˍ
|
|
|
|
|
|
|
|
|
